NDC 49591-126-11 - VARIZIG
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49591-126
- Requested NDC
- 49591-126-11
- Package NDCs from labels
- 49591-126-11, 49591-126-51
- Manufacturer
- Kamada Ltd.
- Effective date
- 2026-02-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VARIZIG - Kamada Ltd. | Kamada Ltd. | 2026-02-10 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49591-126-11 | VARIZIG | 1.2 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 1.2 | 5 | |
| 49591-126-51 | VARIZIG | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49591-126-11 | ML - Milliliter | 49591-126 | 91cdf8fb-466d-4557-a5f4-a0d67d32475e | 1 | 2024-11-05 |
| 49591-126-51 | ML - Milliliter | 49591-126 | 55d6498a-1e80-4735-ab32-cf993231dcb5 | 1 | 2024-11-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | 6OZP39ZG8H |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| Virus Nosode 4003 | VIRUS NOSODE | Professional Complementary Health Formulas | 626d937d-45db-4ccf-a75b-e961e2a80852 | 2026-01-08 | Warnings | 33T61IWL27 |
| Low Virus Nosode 4023 | LOW VIRUS NOSODE | Professional Complementary Health Formulas | 670965b0-9b0b-4068-b089-701db0a5ac13 | 2026-01-08 | Warnings | 33T61IWL27 |
| Childhood Immunization Detox 6032 | CHILDHOOD IMMUNIZATION DETOX | Professional Complementary Health Formulas | 4d455d07-3197-44d6-99d6-488fcdb50f95 | 2026-01-08 | Warnings | 33T61IWL27 |
| Childhood Diseases Nosode Combination 9408 | CHILDHOOD DISEASES NOSODE COMBINATION | Professional Complementary Health Formulas | a9a7ffcf-03a7-4799-9574-fbbba8a75712 | 2026-01-08 | Warnings | 33T61IWL27 |
| Shingles Nosode 4028 | SHINGLES NOSODE | Professional Complementary Health Formulas | e71d917a-af9f-41e9-a3de-cb588db7e022 | 2026-01-08 | Warnings | 33T61IWL27 |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.